Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Hallmarks of Cancer: New Dimensions

Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887 · see citing works

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Garon, E. B., Rizvi, N. A., Hui, R., Leighl, N., Balmanoukian, A. S., Eder, J. P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501824 · Cited by 6,198 · see citing works

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887 · see citing works

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works

Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis

Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · see citing works

Interaction between microbiota and immunity in health and disease

Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947 · see citing works

Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · see citing works

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · see citing works

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288 · see citing works

Intestinal epithelial cells: regulators of barrier function and immune homeostasis

Peterson, L. W., & Artis, D. (2014) · Nature reviews. Immunology · doi:10.1038/nri3608 · Cited by 3,191 · see citing works

EMT Transition States during Tumor Progression and Metastasis

Pastushenko, I., & Blanpain, C. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,866 · see citing works

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · see citing works

The healthy human microbiome

Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891 · see citing works

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781 · cited 1× · see citing works

The gut microbiome in health and in disease

Shreiner, A. B., Kao, J. Y., & Young, V. B. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000139 · Cited by 1,695 · see citing works

Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508 · see citing works

The gut-liver axis and the intersection with the microbiome

Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · see citing works

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407 · see citing works

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx108 · Cited by 1,310 · see citing works

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.040 · Cited by 964 · see citing works

The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL

Aykut, B., Pushalkar, S., Chen, R., Li, Q., Abengozar, R., Kim, J. I., Shadaloey, S. A., Wu, D., Preiss, P., Verma, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1608-2 · Cited by 883 · see citing works

GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon

Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., Mellinger, J. D., Smith, S. B., Digby, G. J., Lambert, N. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4466 · Cited by 789 · see citing works

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

Bender, M. J., McPherson, A. C., Phelps, C. M., Pandey, S. P., Laughlin, C. R., Shapira, J. H., Medina Sanchez, L., Rana, M., Richie, T. G., Mims, T. S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.011 · Cited by 732 · see citing works

Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma

Feng, J., Li, J., Wu, L., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01629-4 · Cited by 698 · see citing works

Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice

Wong, S. H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T. N. Y., Tsoi, H., Wu, W. K. K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.022 · Cited by 634 · see citing works

The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

Petit, I., Jin, D. K., & Rafii, S. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.007 · Cited by 605 · see citing works

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

Lam, K. C., Araya, R. E., Huang, A., Chen, Q., Di Modica, M., Rodrigues, R. R., Lopès, A., Johnson, S. B., Schwarz, B., Bohrnsen, E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.019 · Cited by 604 · see citing works

The Intestinal Microbiota and Colorectal Cancer

Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 588 · see citing works

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

Jin, Y., Dong, H., Xia, L., Yang, Y., Zhu, Y., Shen, Y., Zheng, H., Yao, C., Wang, Y., & Lu, S. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.04.007 · Cited by 573 · see citing works

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Routy, B., Lenehan, J. G., Miller, W. H., Jamal, R., Messaoudene, M., Daisley, B. A., Hes, C., Al, K. F., Martinez-Gili, L., Punčochář, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02453-x · Cited by 526 · see citing works

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

Woodhouse, R., Li, M., Hughes, J., Delfosse, D., Skoletsky, J., Ma, P., Meng, W., Dewal, N., Milbury, C., Clark, T., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237802 · Cited by 516 · see citing works

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies

(2022) · doi:10.1186/s13045-022-01273-9 · Cited by 495 · see citing works

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

Behary, J., Amorim, N. M. L., Jiang, X., Raposo, A. E., Gong, L., McGovern, E., Ibrahim, R., Chu, F., Stephens, C., Jebeili, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20422-7 · Cited by 470 · see citing works

Part 1: The Human Gut Microbiome in Health and Disease.

Bull, M. J., & Plummer, N. T. (2014) · PubMed Central · Cited by 459 · see citing works

Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice

Tsoi, H., Chu, E. S., Zhang, X., Sheng, J., Nakatsu, G., Ng, S. C., Chan, A. W. H., Chan, F. K. L., Sung, J. J. �., & Yu, J. Q. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.009 · Cited by 437 · see citing works

Bifidobacterium mechanisms of immune modulation and tolerance

Gavzy, S. J., Kensiski, A., Lee, Z. L., Mongodin, E. F., Ma, B., & Bromberg, J. S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2291164 · Cited by 375 · see citing works

Gut microbiome in HCC – Mechanisms, diagnosis and therapy

Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 370 · see citing works

<i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy

Griffin, M. E., Espinosa, J., Becker, J. L., Luo, J.-D., Carroll, T. S., Jha, J. K., Fanger, G. R., & Hang, H. C. (2021) · Science · doi:10.1126/science.abc9113 · Cited by 366 · see citing works

Gut microbiome and its role in colorectal cancer

Reberšek, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09054-2 · Cited by 365 · see citing works

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer

Liang, Q., Li, T., Nakatsu, G., Chen, Y., Yau, T. O., Chu, E. S., Wong, S. H., Szeto, C. H., Ng, S. C., Chan, F. K. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318532 · Cited by 344 · see citing works

Lactobacillus gallinarum -derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis

Fong, W., Li, Q., Ji, F., Liang, W., Lau, H. C.-H., Kang, X., Liu, W., To, K. K. W., Zuo, Z., Li, X., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329543 · Cited by 325 · see citing works

Dysbiosis of human gut microbiome in young-onset colorectal cancer

Yang, Y., Du, L., Shi, D., Kong, C., Liu, J., Liu, G., Li, X., & Ma, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-27112-y · Cited by 303 · see citing works

Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization

Xu, C., Fan, L., Lin, Y., Shen, W., Qi, Y., Zhang, Y., Chen, Z., Wang, L., Long, Y., Hou, T., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1980347 · Cited by 294 · see citing works

Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection

Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291 · see citing works

Microbiome, Inflammation, and Cancer

Francescone, R., Hou, V., & Grivennikov, S. I. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000048 · Cited by 269 · see citing works

Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy

Campbell, C., Kandalgaonkar, M. R., Golonka, R. M., Yeoh, B. S., Vijay–Kumar, M., & Saha, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020294 · Cited by 256 · see citing works

Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity

Wu, J., Li, Q., & Fu, X. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.03.003 · Cited by 254 · see citing works

Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

Bhat, A. A., Nisar, S., Singh, M. K., Ashraf, B., Masoodi, T., Prasad, C. P., Sharma, A., Maacha, S., Karedath, T., Hashem, S., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12295 · Cited by 245 · see citing works

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., et al. (2023) · Science · doi:10.1126/science.abo2296 · Cited by 243 · see citing works

Dysbiosis of Gut Microbiota and Short‐Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes

Tan, C., Wu, Q., Wang, H., Gao, X., Xu, R., Cui, Z., Zhu, J., Zeng, X., Zhou, H., He, Y., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1861 · Cited by 229 · see citing works

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma

Lee, P.-C., Wu, C.-J., Hung, Y.-W., Lee, C. J., Chi, C.-T., Lee, I.-C., Yu-Lun, K., Chou, S.-H., Luo, J.-C., Hou, M.-C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004779 · Cited by 217 · see citing works

Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging

Biragyn, A., & Ferrucci, L. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30095-0 · Cited by 206 · see citing works

Secretory IgA in the Coordination of Establishment and Maintenance of the Microbiota

Pabst, O., Cerovic, V., & Hornef, M. W. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.002 · Cited by 201 · see citing works

Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies

Xie, Y., Gao, Q., Cai, G. X., Sun, X. M., Zou, T.-H., Chen, H. M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X. Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 192 · see citing works

Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial Cells

Wei, J., Nagy, T. A., Vilgelm, A. E., Zaika, E. I., Ogden, S. R., Romero–Gallo, J., Piazuelo, M. B., Correa, P., Washington, M. K., El-Rifai, W. M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.018 · Cited by 190 · see citing works

Commensal bacteria stimulate antitumor responses via T cell cross-reactivity

Bessell, C. A., Isser, A., Havel, J. J., Lee, S., Bell, D. R., Hickey, J. W., Chaisawangwong, W., Bieler, J. G., Srivastava, R. M., Kuo, F., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135597 · Cited by 185 · see citing works

ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer’s patches to promote host-microbiota mutualism

Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C. E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.010 · Cited by 181 · see citing works

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer

Malapelle, U., Sirera, R., Lewintre, E. J., Reclusa, P., Fariñas, S. C., Blasco, A., Pisapia, P., Rolfo, C. D., & Camps, C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1288568 · Cited by 172 · see citing works

Gut microbiome in modulating immune checkpoint inhibitors

Li, X., Zhang, S., Guo, G., Han, J., & Yu, J. Q. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104163 · Cited by 172 · see citing works

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy

Kang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101478 · Cited by 167 · see citing works

Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection

Wang, C., Li, Q., & Ren, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01873 · Cited by 167 · see citing works

Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages

Luo, Z., Xia, K., Liu, Y.-W., Liu, J., Rao, S., Hu, X., Chen, C., Xu, R., Wang, Z., & Xie, H. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304515 · Cited by 165 · see citing works

Correlation between human gut microbiome and diseases

Madhogaria, B., Bhowmik, P., & Kundu, A. (2022) · Infectious Medicine · doi:10.1016/j.imj.2022.08.004 · Cited by 164 · see citing works

The glycolytic process in endothelial cells and its implications

Susan, W. S. L., & Shi, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00647-y · Cited by 163 · see citing works

Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression

Brennan, C. A., Clay, S. L., Lavoie, S., Bae, S., Lang, J. K., Fonseca‐Pereira, D., Rosinski, K. G., Ou, N., Glickman, J. N., & Garrett, W. S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1987780 · Cited by 162 · see citing works

Dietary Lactobacillus -Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy

Kawanabe-Matsuda, H., Takeda, K., Nakamura, M., Makino, S., Karasaki, T., Kakimi, K., Nishimukai, M., Ohno, T., Omi, J., Kano, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0929 · Cited by 157 · see citing works

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Björk, J. R., Bolte, L. A., Maltez Thomas, A., Lee, K. A., Rossi, N., Wind, T. T., Smit, L. M., Armanini, F., Asnicar, F., Blanco-Miguez, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02803-3 · Cited by 156 · see citing works

Calpain Activation by the Shigella flexneri Effector VirA Regulates Key Steps in the Formation and Life of the Bacterium's Epithelial Niche

Bergounioux, J., Elisee, R., Prunier, A., Donnadieu, F., Sperandio, B., Sansonetti, P. J., & Arbibe, L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.013 · Cited by 156 · see citing works

Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming

Li, Q., Cao, L., Tian, Y., Zhang, P., Ding, C., Lu, W., Jia, C., Shao, C., Liu, W., Wang, D., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000752 · Cited by 150 · see citing works

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target

Zhang, M., Liu, J., & Xia, Q. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00442-x · Cited by 149 · see citing works

The breakthrough of the microbiota

Kroemer, G., & Zitvogel, L. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2018.4 · Cited by 147 · see citing works

Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)

Zhao, W., Lei, J., Ke, S., Chen, Y., Xiao, J., Wang, L., Wang, L., Ren, Y., Alnaggar, M., Qiu, H., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102315 · Cited by 147 · see citing works

Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management

Tang, L., Wang, J., Lin, N., Zhou, Y., He, W., Liu, J., & Ma, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.800879 · Cited by 135 · see citing works

Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity

Choi, Y., Lichterman, J. N., Coughlin, L. A., Poulides, N., Li, W., Del Valle, P., Palmer, S. N., Gan, S., Kim, J., Zhan, X., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abo2003 · Cited by 132 · see citing works

Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway

Shao, S., Jia, R., Zhao, L., Zhang, Y., Guan, Y., Wen, H., Liu, J., Zhao, Y., Feng, Y., Zhang, Z., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153606 · Cited by 131 · see citing works

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma

Zheng, R., Wang, G., Pang, Z., Ran, N., Gu, Y., Guan, X., Yuan, Y., Zuo, X., Pan, H., Zheng, J., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3045 · Cited by 130 · see citing works

Measuring the diversity of the human microbiota with targeted next-generation sequencing

Finotello, F., Mastrorilli, E., & Camillo, B. D. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw119 · Cited by 127 · see citing works

Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives

Said, S. S., & Ibrahim, W. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041143 · Cited by 127 · see citing works

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 105 · see citing works

Adaptive immunity in the host–microbiota dialog

Feng, T., & Elson, C. O. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.60 · Cited by 105 · see citing works

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients

Malard, F., Vekhoff, A., Lapusan, S., Isnard, F., D’Incan, E., Rey, J., Saillard, C., Thomas, X., Ducastelle-Leprêtre, S., Paubelle, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23376-6 · Cited by 102 · see citing works

Interactions between Innate Immunity, Microbiota, and Probiotics

Giorgetti, G., Brandimarte, G., Fabiocchi, F., Ricci, S., Flamini, P., Sandri, G., Trotta, M. C., Elisei, W., Penna, A., Lecca, P. G., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/501361 · Cited by 99 · see citing works

Dysbiosis of skin microbiome and gut microbiome in melanoma progression

Mekadim, C., Skalníková, H. K., Čížková, J., Cizkova, V., Palanová, A., Horák, V., & Mrázek, J. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02458-5 · Cited by 94 · see citing works

Bile Acid Receptors and Liver Cancer

Wang, X., Fu, X., Ness, C. V., Meng, Z., Ma, X., & Huang, W. (2012) · Current Pathobiology Reports · doi:10.1007/s40139-012-0003-6 · Cited by 91 · see citing works

Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment

Ruo, S. W., Alkayyali, T., Win, M. T. T., Tara, A., Joseph, C. G., Kannan, A., Srivastava, K., Ochuba, O., Sandhu, J. K., Went, T. R., et al. (2021) · Cureus · doi:10.7759/cureus.17472 · Cited by 87 · see citing works

Inhibition of UBA6 by inosine augments tumour immunogenicity and responses

(2022) · doi:10.1038/s41467-022-33116-z · Cited by 82 · see citing works

Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy

Cao, W., Zheng, C., Xu, X., Jin, R., Huang, F., Shi, M., He, Z., Luo, Y., Liu, L., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1076245 · Cited by 82 · see citing works

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

Khouzam, R. A., Zaarour, R. F., Brodaczewska, K. K., Azakir, B., Venkatesh, G. H., Thiery, J., Terry, S., & Chouaı̈b, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828875 · Cited by 80 · see citing works

Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling

Sun, Y., Wu, C., Ma, J., Yang, Y. S., Man, X., Wu, H., & Li, S.-D. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.07.009 · Cited by 80 · see citing works

Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study

Wei, Z., Yang, B., Tang, T., Xiao, Z., Ye, F., Li, X., Wu, S., Huang, J., & Jiang, S. (2023) · Cancer Medicine · doi:10.1002/cam4.5772 · Cited by 79 · see citing works

The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies

Kang, Y., Cai, Y., & Yang, Y. X. (2021) · Liver Cancer · doi:10.1159/000521358 · Cited by 76 · see citing works

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S. K., Gupta, A. A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08530-z · Cited by 75 · see citing works

The heightened importance of the microbiome in cancer immunotherapy

Villemin, C., Six, A., Neville, B. A., Lawley, T. D., Robinson, M. J., & Bakdash, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.002 · Cited by 75 · see citing works

Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib

Bauml, J. M., Li, B. T., Velcheti, V., Govindan, R., Fontecedro, A. C., Dooms, C., Takahashi, T., Duda, A. W., Odegaard, J. I., Cruz‐Guilloty, F., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.10.007 · Cited by 73 · see citing works

Microbiome-derived carnitine mimics as previously unknown mediators of gut-brain axis communication

Hulme, H., Meikle, L. M., Strittmatter, N., van der Hooft, J. J. J., Swales, J. G., Bragg, R. A., Villar, V. H., Ormsby, M. J., Barnes, S. A., Brown, S. L., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax6328 · Cited by 73 · see citing works

Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma

Abe, S., Masuda, A., Matsumoto, T., Inoue, J., Toyama, H., Sakai, A., Kobayashi, T., Tanaka, T., Tsujimae, M., Yamakawa, K., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-023-02069-5 · Cited by 72 · see citing works

Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females

Huang, Y.-F., Chen, Y.-J., Fan, T.-C., Chang, N.-C., Chen, Y.-J., Midha, M. K., Chen, T.-H., Yang, H.-H., Wang, Y.-T., Yu, A. L., et al. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0329-y · Cited by 72 · see citing works

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors

Joachim, L., Göttert, S., Sax, A., Steiger, K., Neuhaus, K., Heinrich, P., Fan, K., Orberg, E. T., Kleigrewe, K., Ruland, J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104834 · Cited by 70 · see citing works

Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression

Yang, R., & Li, Q. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221114100 · Cited by 70 · see citing works

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab

Martini, G., Ciardiello, D., Dallio, M., Famiglietti, V., Esposito, L., Corte, C. M. D., Napolitano, S., Fasano, M., Gravina, A. G., Romano, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34033 · Cited by 69 · see citing works

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort

Reichard, C. A., Naelitz, B. D., Wang, Z., Jia, X., Li, J., Stampfer, M. J., Klein, E. A., Hazen, S. L., & Sharifi, N. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0766 · Cited by 64 · see citing works

Intestinal Microbiota Predicts Lung Cancer Patients at Risk of Immune-Related Diarrhea

Liu, T., Xiong, Q., Li, L., & Hu, Y. (2019) · Immunotherapy · doi:10.2217/imt-2018-0144 · Cited by 64 · see citing works

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Ruíz-Patiño, A., Arrieta, O. G., Cardona, A. F., Martin, C. M., Raez, L. E., Zatarain-Barrón, Z. L., Barrón, F., Ricaurte, L., Bravo-Garzón, M. A., Mas, L. A., et al. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13272 · Cited by 63 · see citing works

Protective effects of a new generation of probiotic Bacteroides fragilis against colitis in vivo and in vitro

He, Q., Niu, M., Bi, J., Du, N., Liu, S., Yang, K., Li, H., Yao, J., Du, Y., & Duan, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-42481-8 · Cited by 61 · see citing works

Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors

Santoni, M., Piva, F., Conti, A., Santoni, A., Cimadamore, A., Scarpelli, M., Battelli, N., & Montironi, R. (2018) · European Urology · doi:10.1016/j.eururo.2018.05.033 · Cited by 60 · see citing works

Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients

Kunzmann, A. T., Proença, M. A., Jordão, H. W. T., Jirásková, K., Schneiderová, M., Levý, M., Liška, V., Büchler, T., Vodičková, Ľ., Vymetalkova, V. P., et al. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03649-1 · Cited by 60 · see citing works

Phospholipid metabolites of the gut microbiota promote hypoxia-induced intestinal injury via CD1d-dependent γδ T cells

Li, Y., Wang, Y., Shi, F., Zhang, X., Zhang, Y., Bi, K., Chen, X., Li, L., & Diao, H. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096994 · Cited by 60 · see citing works

The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy

Wang, M., Yang, G., Tian, Y., Zhang, Q., Liu, Z., & Xin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183331 · Cited by 59 · see citing works

Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects

Liang, Q., Wong, S. H., Szeto, C. H., Chu, E. S., Lau, H. C.-H., Chen, Y., Fang, J., Yu, J. Q., & Sung, J. J. �. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15171 · Cited by 57 · see citing works

New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer

Caliceti, C., Punzo, A., Silla, A., Simoni, P., Roda, G., & Hrelia, S. (2022) · Nutrients · doi:10.3390/nu14142964 · Cited by 52 · see citing works

From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin

Lai, Y.-R., Chang, Y., Ma, J., Chiu, C., Kuo, M., & Lai, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760451 · Cited by 52 · see citing works

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies

Guo, C., Kong, L., Xiao, L., Liu, K., Cui, H., Xin, Q., Gu, X., Jiang, C., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01135-y · Cited by 46 · see citing works

Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association

Kneis, B., Wirtz, S. J., Weber, K., Denz, A., Gittler, M. M., Geppert, C. I., Brunner, M., Krautz, C., Siebenhüner, A. R., Schierwagen, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043265 · Cited by 44 · see citing works

Changes in gut microbiota composition with age and correlations with gut inflammation in rats

Chen, M., Feng, S., Hao, Z., Dong, C., & Liu, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265430 · Cited by 44 · see citing works

Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets

Jiang, H., Zeng, W. G., Zhang, X., Li, Y., Wang, Y., Peng, A., & Cao, D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1211855 · Cited by 43 · see citing works

Neonatal gut colonization by Bifidobacterium is associated with higher childhood cytokine responses

Rabe, H., Lundell, A., Sjöberg, F., Ljung, A., Strömbeck, A., Gio-Batta, M., Maglio, C., Nordström, I., Andersson, K. M., Nookaew, I., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1847628 · Cited by 42 · see citing works

Akkermansia muciniphila might improve anti‐PD‐1 therapy against HCC by changing host bile acid metabolism

Lan, X., Ma, J., Huang, Z., Chen, N., Jin, X., 翁玉蓉, Xu, Y., & Hu, Y. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3639 · Cited by 41 · see citing works

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors

Wu, Z., Zhang, S., Li, L., Huang, Z., Huang, D., & Hu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887383 · Cited by 38 · see citing works

Exploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis

Ševčíková, A., Mladosievičová, B., Mego, M., & Čierniková, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417199 · Cited by 37 · see citing works

Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer

Said, S. S., & Ibrahim, W. N. (2024) · Biomedicines · doi:10.3390/biomedicines12020369 · Cited by 32 · see citing works

Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity

Kunika, Frey, N., & Rangrez, A. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087261 · Cited by 31 · see citing works

Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer

Yoon, H., Kim, N.-E., Park, J., Shin, C. M., Kim, N., Lee, D. H., Park, J. Y., Choi, C. H., Kim, J. G., & Park, Y. S. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.112 · Cited by 31 · see citing works

Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy

Zhang, H., & Xu, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1257515 · Cited by 30 · see citing works

Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer

Löwenmark, T., Li, X., Löfgren‐Burström, A., Zingmark, C., Ling, A., Kellgren, T. G., Larsson, P. G., Ljuslinder, I., Wai, S. N., Edin, S., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03179-4 · Cited by 29 · see citing works

Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy

Xu, L., Qi, Y., Jiang, Y., Ji, Y., Zhao, Q., Wu, J., Lu, W., Wang, Y., Chen, Q., & Wang, C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1165 · Cited by 27 · see citing works

The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host

Huang, J., & Mao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029033 · Cited by 27 · see citing works

Circulating markers of microbial translocation and host response to bacteria with risk of colorectal cancer: a prospective, nested case-control study in men

Shi, M., Zong, X., Hur, J., Birmann, B. M., Martı́nez-Maza, O., Epeldegui, M., Chan, A. T., Giovannucci, E. L., & Cao, Y. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104566 · Cited by 25 · see citing works

Cholesterol in colorectal cancer: an essential but tumorigenic precursor?

He, X., Lan, H., Jin, K., & Liu, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1276654 · Cited by 23 · see citing works

Effect of shRNA Mediated Silencing of YB-1 Protein on the Expression of Matrix Collagenases in Malignant Melanoma Cell In Vitro

Ibrahim, W. N., Doolaanea, A. A., & Abdull Rasad, M. S. B. (2018) · Cells · doi:10.3390/cells7010007 · Cited by 23 · see citing works

Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors (Review)

Wang, J., Yang, H.-R., Wang, D.-J., & Wang, X.-X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12205 · Cited by 21 · see citing works

The role of non-H. pylori bacteria in the development of gastric cancer.

Li, Q., & Yu, H. (2020) · PubMed Central · Cited by 21 · see citing works

Bifidobacterium in anticancer immunochemotherapy: friend or foe?

Procaccianti, G., Roggiani, S., Conti, G., Brigidi, P., Turroni, S., & D’Amico, F. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.23 · Cited by 19 · see citing works

Gut-Derived Endotoxin and Telomere Length Attrition in Adults with and without Type 2 Diabetes

Al‐Daghri, N. M., Abdi, S., Sabico, S., Alnaami, A. M., Wani, K., Ansari, M. G. A., Khattak, M. N. K., Khan, N., Tripathi, G., Chrousos, G. P., et al. (2021) · Biomolecules · doi:10.3390/biom11111693 · Cited by 19 · see citing works

Microbiota and the Immune System—Actors in the Gastric Cancer Story

Majewski, M., Mertowska, P., Mertowski, S., Smolak, K., Grywalska, E., & Torres, K. (2022) · Cancers · doi:10.3390/cancers14153832 · Cited by 19 · see citing works

Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy

Mishra, S., Amatya, S. B., Salmi, S., Koivukangas, V., Karihtala, P., & Reunanen, J. (2022) · Cancers · doi:10.3390/cancers14205121 · Cited by 18 · see citing works

The Potential Immunomodulatory Effect of Bifidobacterium longum subsp. longum BB536 on Healthy Adults through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood

Li, Y., Arai, S., Kato, K., Iwabuchi, S., Iwabuchi, N., Mutoh, N., Motobayashi, H., Ebihara, S., Tanaka, M., & Hashimoto, S. (2023) · Nutrients · doi:10.3390/nu16010042 · Cited by 17 · see citing works

Direct Effects of Lipopolysaccharide on Human Pancreatic Cancer Cells

Massoumi, R. L., Teper, Y., Ako, S., Ye, L., Wang, E., Hines, O. J., & Eibl, G. (2021) · Pancreas · doi:10.1097/mpa.0000000000001790 · Cited by 17 · see citing works

Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic

Pang, S. A., Elkrief, A., Capella, M. P., & Miller, W. H. (2023) · Current Oncology · doi:10.3390/curroncol30090570 · Cited by 16 · see citing works

Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in Apc Min/+ mice

Chat, H., Dalmasso, G., Godfraind, C., Bonnin, V., Beyrouthy, R., Bonnet, M., Barnich, N., Mettouchi, A., Lemichez, E., Bonnet, R., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229569 · Cited by 15 · see citing works

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far

Prasad, S. K., Bhat, S., Shashank, D., Akshatha, C. R., Sindhu, R., Rachtanapun, P., Devegowda, D., Santhekadur, P. K., & Sommano, S. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836004 · Cited by 15 · see citing works

Downregulation of AKT/mTOR signaling pathway for Salmonella-mediated autophagy in human anaplastic thyroid cancer

Wu, L.-H., Pangilinan, C. R., & Lee, C. (2022) · Journal of Cancer · doi:10.7150/jca.75163 · Cited by 14 · see citing works

Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors

Pei, B., Ma, X., Wu, N., Wang, C., & Yang, W. (2023) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2023.03.05 · Cited by 13 · see citing works

The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy

Gao, W., Liu, Q., Zhou, Y., Yang, M., & Yu, Y. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231206705 · Cited by 12 · see citing works

Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound–Guided Fine-Needle Aspiration–Derived Samples

Nakano, S., Kawamoto, Y., Komatsu, Y., Saito, R., Ito, K., Yamamura, T., Harada, K., Yuki, S., Kawakubo, K., Sugiura, R., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002028 · Cited by 11 · see citing works

High expression of endothelial progenitor cell‑induced angiogenic markers is associated with bile acid levels in HCC

Chen, J., Wang, L., Li, R., Jiao, Y., & Yu, W. (2020) · Oncology Letters · doi:10.3892/ol.2020.11815 · Cited by 8 · see citing works

Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota

Rahimi, A. R., Baghernejadan, Z., Hazrati, A., Malekpour, K., Samimi, L. N., Najafi, A., Falak, R., & Khorramdelazad, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118014 · Cited by 39 · see citing works

Microbial signatures in metastatic cancer

Bautista, J., Fuentes-Yépez, M. P., Adatty-Molina, J., & López‐Cortés, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1654792 · Cited by 31 · see citing works

Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments

Eiman, L., Moazzam, K., Anjum, S., Kausar, H., Sharif, E. A. M., & Ibrahim, W. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575452 · Cited by 25 · see citing works

Recent research progress and clinical status of immunotherapy for colorectal cancer

Huo, Z., Liu, G., & Li, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.06.089 · Cited by 23 · see citing works

A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine

Mokhtari, R. B., Sambi, M., Shekari, F., Satari, K., Ghafoury, R., Ashayeri, N., Eversole, P., Baluch, N., Harless, W. W., Muscarella, L. A., et al. (2025) · Biomolecules · doi:10.3390/biom15091304 · Cited by 21 · see citing works

The Gut–Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy

Scuderi, S. A., Ardizzone, A., Calcaterra, E., Palermo, N., Luca, F. D., Catalfamo, A., Esposito, E., & Capra, A. P. (2025) · Biomedicines · doi:10.3390/biomedicines13092172 · Cited by 10 · see citing works

The role of the microbiome in endometrial carcinoma: Pathogenesis, biomarkers, and therapeutic prospects

Abdalla, W., Ibrahim, W. N., Abdallah, A. M., Al‐Asmakh, M., & Said, S. S. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70070 · Cited by 9 · see citing works

The tumor ecosystem: Rewiring an open, systemically integrated network for therapeutic gain

Chiodelli, P., Papait, A., Agoni, L., Quaglia, F., Silini, A. R., & Parolini, O. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119047 · Cited by 10 · see citing works

Activation of cGAS ‐ STING Pathway by DAI ‐Triggered Ferroptosis in CRC Cells Reprograms TAMs Balance to Promote Anti‐Tumor Immunity

Cheng, P., Yang, Q., Zhang, X., Wang, Q., & Zhong, B. (2025) · Cancer Science · doi:10.1111/cas.70196 · Cited by 8 · see citing works

Phage therapy in oncology: opportunities for cancer prevention and treatment

Mutalik, V. K., Inman, J. L., Chang, H., Arkin, A., & Mao, J.-H. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.02.001 · Cited by 5 · see citing works

Intratumoral microbiota and metabolites: dual roles in cancer progression and therapeutic opportunities

Zhai, Z., Li, X., Shang, S., Ma, S., Liang, X., Yin, S., Wu, M., Yu, J., Song, Q., & Chen, D. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02623-z · Cited by 5 · see citing works

Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment

Dong, W., Qian, X., Liu, H., Huo, J. A., & Wang, W. (2026) · Biomolecules · doi:10.3390/biom16010160 · Cited by 5 · see citing works

Snake venom in conjugation with silica nanoparticles: an emerging cancer therapy

Azam, D., Arshad, N., Khalid, M., Hassan, S., Anjum, S., Sharif, E., & Ibrahim, W. N. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0056 · Cited by 2 · see citing works

Intratumoral Microbiota Correlates with AP-2 Expression: A Pan-Cancer Map with Cohort-Specific Prognostic and Molecular Footprints

Kołat, D., Gromek, P., Zhao, L.-Y., Kałuzińska‐Kołat, Ż., Kciuk, M., Kontek, R., & Płuciennik, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311587 · Cited by 2 · see citing works

Bidirectional microbiota-cancer crosstalk: Emerging platforms for advanced diagnostics and precision therapeutics in oncology

Javadi, M. M., Ahmadbeigi, G., Ataollahi, H., Boroomand, S., Kia, S. K., Soleimani, N., Zia-Jahromi, N., & Hedayati, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119745 · Cited by 2 · see citing works

Microbial metabolites and the gut-lung axis in non-small cell lung cancer immunotherapy: evidence boundaries and translational implications

Zheng, F., Zhang, Y., & Zhong-xin, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1890287 · Cited by 2 · see citing works

The role of human microbiome in cancer metastasis: Mechanisms and therapeutic implications

Islam, M. R., Maliha, A., Hossain, M. M., Ahmed, I., Hossain, M. S., Mishu, M. A., & Ghosh, A. (2026) · Advances in Redox Research · doi:10.1016/j.arres.2026.100162 · Cited by 1 · see citing works

Panflemmotic triggers to metastatic pathways: Complex signatures of tumorigenesis in the colonic microenvironment

Reyed, R. M., & Prabhakar, P. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36500-3.00008-8 · Cited by 1 · see citing works

A Narrative Approach to Mismatch Repair-Deficient Endometrial Cancer

Barberis, M. C. P., & Zhan, Y. (2026) · Journal of Molecular Pathology · doi:10.3390/jmp7020017

The mechanism of lncRNA PVT1 in oral squamous cell carcinoma

Ren, Q., Li, X., Li, Y., Hu, X., Liu, K., Tang, S., Zhang, Z., Wen, Z., Wang, M., Wang, Q., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1754726

The role of artificial intelligence in predicting immunotherapy treatment outcomes based on gut microbiota composition in cancer patients: a meta-analysis

Alhassan, L., Alrabadi, B., Batarseh, S. F., Alghzawi, Y., Bandak, N., Badwan, A., & Alkayed, H. A. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2717074

Perspective Chapter: Microbiome Predictive Value for Immunotherapy Response

Gales, L. N., Ghencea, I. A., Serban, E. C., & Trifanescu, O. G. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1017715

Microbiome as a modulator of immunotherapy: Synergistic effects of the microbiome in immunotherapy

Vohra, V., Malik, G., Mittal, N., Dhanawat, M., & Girdhar, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00005-4

Polysaccharide-mediated modulation of gut microbiota and lysine lactylation: implications for tumor microenvironment remodeling and cancer immunotherapy

Yang, S., Long, D., Qiu, W., Morris-Natschke, S. L., Ma, G., Xu, X., Zhao, Z., Li, Y., Zou, Q., & Wu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1924150

From Dysbiosis to Symbiosis: Using the Gut Microbiome to Improve Cancer Outcomes

Nassar, S. A. (2026) · Medical Sciences · doi:10.3390/medsci14060669

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes

Yan, J., Yang, L., Ren, Q., Zhu, C., Du, H., Wang, Z., Qi, Y., Xian, X., & Chen, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1471273 · Cited by 47 · see citing works

Gut microbiota-mediated immunomodulation in tumor

Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental &amp; Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112 · see citing works

The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review

Araji, G., Maamari, J., Ahmad, F. A., Zareef, R. O., Chaftari, P. S., & Yeung, S. J. (2021) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-21-10 · Cited by 18 · see citing works

The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions

Kiousi, D. E., Kouroutzidou, A. Z., Neanidis, K., Karavanis, E., Matthaios, D., Pappa, A., & Galanis, Α. (2023) · Cancers · doi:10.3390/cancers15072101 · Cited by 58 · see citing works

Gut microbiome in modulating immune checkpoint inhibitors

Bade, J. D., Shaik, A. R., Nelluri, K. D. D., Nelluri, S., & Alaparthi, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00012-1